Presentation is loading. Please wait.

Presentation is loading. Please wait.

Suppression of pathergy in pyoderma gangrenosum with infliximab allowing for successful tendon debridement  Paul A. Leiphart, BA, Charlene C. Lam, MD,

Similar presentations


Presentation on theme: "Suppression of pathergy in pyoderma gangrenosum with infliximab allowing for successful tendon debridement  Paul A. Leiphart, BA, Charlene C. Lam, MD,"— Presentation transcript:

1 Suppression of pathergy in pyoderma gangrenosum with infliximab allowing for successful tendon debridement  Paul A. Leiphart, BA, Charlene C. Lam, MD, Galen T. Foulke, MD  JAAD Case Reports  Volume 4, Issue 1, Pages (January 2018) DOI: /j.jdcr Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions

2 Fig 1 A, Pyoderma gangrenosum at admission with exposed tibialis anterior tendon. B, Edema and desiccation of the tibialis anterior tendon at follow-up. C, Granulation tissue development following debridement of the exposed tendon. D, Near resolution of the ulcer after 1 year of treatment with infliximab and minocycline. JAAD Case Reports 2018 4, DOI: ( /j.jdcr ) Copyright © 2017 American Academy of Dermatology, Inc. Terms and Conditions


Download ppt "Suppression of pathergy in pyoderma gangrenosum with infliximab allowing for successful tendon debridement  Paul A. Leiphart, BA, Charlene C. Lam, MD,"

Similar presentations


Ads by Google